Physician profile
Daryl Ross
NPI 1285099184
$903.61
in general payments reported to CMS, 2019-2025
17 companies · $343 in 2025
The $343 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $95.78 · 2023: $200 · 2024: $139 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $683.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $316.35 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $109.35 | 2021-2025 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $88.14 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $66.45 | 2021-2025 | Trintellix |
| Alkermes, INC. | $55.48 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $38.74 | 2025 | Caplyta |
| Lundbeck LLC | $30.20 | 2023-2025 | Rexulti |
| Almatica Pharma LLC | $30.06 | 2023 | Loreev Xr |
| Boston Scientific Corporation | $22.97 | 2022 | |
| Neuronetics, INC. | $22.18 | 2025 | Neurostar Tms Therapy System |
| Braeburn INC. | $20.86 | 2025 | Brixadi |
| Idorsia Pharmaceuticals US INC | $20.11 | 2023 | Quviviq |
| Neos Therapeutics, Lp | $18.60 | 2024 | Adzenys Xr-Odt |
| Vanda Pharmaceuticals INC. | $16.78 | 2025 | Fanapt |
| Indivior INC. | $16.51 | 2025 | Sublocade |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $16.45 | 2024 | Azstarys |
| Axsome Therapeutics, INC. | $14.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daryl Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.